Browse by author
Lookup NU author(s): Professor Roy Taylor, Dr Ahmad Al-Mrabeh
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
Clinical and pathophysiological studies have shown type 2 diabetes to be a condition mainly caused by excess, yetreversible, fat accumulation in the liver and pancreas. Within the liver, excess fat worsens hepatic responsiveness toinsulin, leading to increased glucose production. Within the pancreas, the β cell seems to enter a survival mode andfails to function because of the fat-induced metabolic stress. Removal of excess fat from these organs via substantialweight loss can normalise hepatic insulin responsiveness and, in the early years post-diagnosis, is associated withβ-cell recovery of acute insulin secretion in many individuals, possibly by redifferentiation. Collectively, these changescan normalise blood glucose levels. Importantly, the primary care-based Diabetes Remission Clinical Trial (DiRECT)showed that 46% of people with type 2 diabetes could achieve remission at 12 months, and 36% at 24 months,mediated by weight loss. This major change in our understanding of the underlying mechanisms of disease permitsa reassessment of advice for people with type 2 diabetes.
Author(s): Taylor R, Al-Mrabeh A, Sattar N
Publication type: Review
Publication status: Published
Journal: The Lancet Diabetes & Endocrinology
Year: 2019
Volume: 7
Issue: 9
Pages: 726-736
Print publication date: 01/09/2019
Online publication date: 13/05/2019
Acceptance date: 11/01/2019
ISSN (print): 2213-8587
ISSN (electronic): 2213-8595
URL: https://doi.org/10.1016/S2213-8587(19)30076-2
DOI: 10.1016/S2213-8587(19)30076-2
